Avid Bioservices Inc (CDMO)

[pphmtoolong]

The share price sucks. However, there will be no reverse split, unless Bavi is a flop. Bavi will not flop. End of RS discussion.

Now seems like an odd time to make a negative assessment of Bavi and Peregrine. The Phase III trial is on track for full enrollment as scheduled. The study will produce two early look-ins and data unblinding next year.

As those who keep track know, Peregrine is moving forward on all fronts as fast as their funds allow. Doesn't smell like Bavi is a flop to me.

GLTA, Especially Bavi-arm Sunrise Trial Patients,

Paul